Sema4 Faces Revenue Concentration Risk as Reproductive Health Exit Looms
Genomics company Sema4 confronts going concern risk tied to heavy revenue dependence on its reproductive health screening segment. The company is exiting this business line despite it representing a substantial portion of total revenue. Analysts assign medium likelihood to the concentration risk materializing.
ViaNews Editorial Team (Markets)•